Matinas BioPharma Holdings (MTNB) Return on Capital Employed [ROCE] (2014 - 2026)
Matinas BioPharma Holdings' Return on Capital Employed [ROCE] came in at -202.49% for Q2 2026, down 35.25 percentage points from -167.24% a year earlier and down 45.07 percentage points from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends
For FY2025, Matinas BioPharma Holdings' Return on Capital Employed [ROCE] was -82.25%, up 69.49 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a five-year change of -35.74 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -151.75% in FY2024 (-78.26 pp), -73.49% in FY2023 (-23.09 pp), -50.40% in FY2022 (-10.38 pp) and -40.03% in FY2021 (+6.49 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q1 2025.
- Year-over-year, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -24.42 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q4 2025 (a gain of 76.78 percentage points), and the weakest in Q1 2025 (a drop of 86.36 percentage points).
- Business Quant data shows MTNB's Return on Capital Employed [ROCE] at -157.42% (Q1 2026), -99.59% (Q4 2025) and -152.56% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Matinas BioPharma Holdings | 15.63 Mn | 3.04 Mn | - | -202.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -202.49% |
| Mar 31, 2026 | -157.42% |
| Dec 31, 2025 | -99.59% |
| Sep 30, 2025 | -152.56% |
| Jun 30, 2025 | -167.24% |
| Mar 31, 2025 | -204.65% |
| Dec 31, 2024 | -176.37% |
| Sep 30, 2024 | -108.17% |
| Jun 30, 2024 | -121.26% |
| Mar 31, 2024 | -118.29% |
| Dec 31, 2023 | -95.73% |
| Sep 30, 2023 | -81.45% |
| Jun 30, 2023 | -67.61% |
| Mar 31, 2023 | -56.64% |
| Dec 31, 2022 | -58.69% |
| Sep 30, 2022 | -57.28% |
| Jun 30, 2022 | -55.91% |
| Mar 31, 2022 | -47.65% |
| Dec 31, 2021 | -41.36% |
| Sep 30, 2021 | -38.07% |
API Access
Matinas BioPharma Holdings Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();